Literature DB >> 8625068

Characterization of focal hepatic tumors. Value of two-phase scanning with spiral computed tomography.

B I Choi1, J K Han, J M Cho, D S Choi, M C Han, H S Lee, C Y Kim.   

Abstract

BACKGROUND: Spiral computed tomography (CT) allows imaging of the liver during the peak contrast material levels due to the capability of fast data acquisition. The objective of this study was to evaluate the usefulness of two-phase spiral CT in the differential diagnosis of focal hepatic tumors.
METHODS: One hundred two patients who had hepatic tumors (211 nodules; 149 hepatocellular carcinomas [HCCs], 36 metastases, and 26 hemangiomas) underwent two-phase spiral CT with 10-mm collimation at 10 mm/second table speed and 120 mL of contrast material injected at the rate of 3 mL/second. Computed tomography images of the hepatic arterial phase and late (equilibrium) phase were obtained at 35-second and 180-second delays, respectively. The enhancement patterns of tumors were divided into six types and were compared with the attenuation of surrounding liver parenchyma: totally high, peripherally high, centrally high, mixed, iso, and low.
RESULTS: The common enhancement patterns of HCC in two-phase spiral CT were totally high in the arterial phase and low (n = 63, 42%) or iso (n = 28, 19%) in the late phase. Metastasis showed peripherally nonnodular high attenuation (n = 9, 25%) or low attenuation (n = 9, 25%) in the arterial phase and low attenuation in the late phase, followed by totally high attenuation in the arterial phase and iso in the late phase (n = 6, 17%). Hemangiomas showed totally or peripherally nodular enhancement in the arterial and late phases (n = 23, 89%). In distinguishing hemangiomas from malignant tumors, totally high or peripherally nodular high attenuation in the late phase was the most useful contrast enhancement pattern (96% of hemangioma vs. 0% of malignant tumors). In distinguishing HCCs from metastases, a combination of contrast enhancement pattern of totally high attenuation in the arterial phase and low in the late phase was the most useful contrast enhancement pattern (42% of HCCs vs. 0% of metastases). The predictability of differentiation between hemangiomas and malignant tumors and between HCCs and metastases was 99% and 90% with spiral CT, respectively.
CONCLUSIONS: Two-phase spiral CT is useful in the differential diagnosis of focal hepatic tumors with evaluation of contrast enhancement patterns.

Entities:  

Mesh:

Year:  1995        PMID: 8625068     DOI: 10.1002/1097-0142(19951215)76:12<2434::aid-cncr2820761206>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

1.  Magnetic resonance-guided upper abdominal biopsies in a high-field wide-bore 3-T MRI system: feasibility, handling, and needle artefacts.

Authors:  Jens-Peter Kühn; Sönke Langner; Katrin Hegenscheid; Matthias Evert; Antje Kickhefel; Norbert Hosten; Ralf Puls
Journal:  Eur Radiol       Date:  2010-05-26       Impact factor: 5.315

2.  Contrast-enhanced multiphase dynamic ultrasonography for the characterization of liver tumors.

Authors:  Sachiko Tanaka; Yoshihiro Hamada; Tatsuya Ioka; Takashi Sugiyama; Iwao Akamatsu; Rena Takakura; Fumi Yoshioka; Akihiko Nakaizumi; Tetsushi Ishida
Journal:  J Med Ultrason (2001)       Date:  2005-06       Impact factor: 1.314

3.  Sonographic characterization of 271 hepatic hemangiomas with typical appearance on CT imaging.

Authors:  Hiroaki Ito; Fumio Tsujimoto; Yasuo Nakajima; Gaku Igarashi; Takanori Okamura; Masaru Sakurai; Sachihiko Nobuoka; Takehito Otsubo
Journal:  J Med Ultrason (2001)       Date:  2012-01-12       Impact factor: 1.314

4.  Computed tomography and magnetic resonance imaging features of lipid-rich neuroendocrine tumors of the pancreas.

Authors:  Yoshihiko Fukukura; Toshikazu Shindo; Michiyo Higashi; Koji Takumi; Tomokazu Umanodan; Tomohide Yoneyama; Takashi Yoshiura
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

5.  Role of contrast enhanced ultrasound in radiofrequency ablation of metastatic liver carcinoma.

Authors:  Jin-Yu Wu; Min-Hua Chen; Wei Yang; Shu-Zhi Lin; Wei Wu; Shan-Shan Yin; Hui Zhang; Kun Yan
Journal:  Chin J Cancer Res       Date:  2012-03       Impact factor: 5.087

6.  Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.

Authors:  Akihiro Tateyama; Yoshihiko Fukukura; Koji Takumi; Toshikazu Shindo; Yuichi Kumagae; Kiyohisa Kamimura; Masayuki Nakajo
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

7.  Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT.

Authors:  Yumi Yanaga; Kazuo Awai; Yoshiharu Nakayama; Takeshi Nakaura; Yoshitaka Tamura; Yoshinori Funama; Masahito Aoyama; Naoki Asada; Yasuyuki Yamashita
Journal:  Radiat Med       Date:  2007-07-27

8.  Quantitative characterization of hepatocellular carcinoma and metastatic liver tumor by CT perfusion.

Authors:  Koichi Hayano; Gaurav S Desai; Avinash R Kambadakone; Jorge M Fuentes; Kenneth K Tanabe; Dushyant V Sahani
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

9.  Feasibility and potential benefits of defining the internal gross tumor volume of hepatocellular carcinoma using contrast-enhanced 4D CT images obtained by deformable registration.

Authors:  Hua Xu; Guanzhong Gong; Hong Wei; Lusheng Chen; Jinhu Chen; Jie Lu; Tonghai Liu; Jian Zhu; Yong Yin
Journal:  Radiat Oncol       Date:  2014-10-16       Impact factor: 3.481

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.